DEC 09, 2019 4:14 PM PST

Astronauts help to advanced personalized medicine

WRITTEN BY: Tara Fernandez

Extreme temperatures and lethal levels of radiation are just some of the hazards faced by astronauts as they traverse the harsh conditions of space.

Additionally, space travelers on extended journeys are also subject to an accelerated aging phenomenon -- with effects like bone density loss, the hardening of blood vessels, and diminishing muscle mass.

Space health researchers like Dr. Annette Sobel, professor at the Texas Tech University of Health Sciences Center, are taking advantage of cutting edge diagnostic technologies to better understand and manage the physically demanding aspects of interplanetary voyages.

Dr. Sobel is part of a team developing personalized medical support to astronauts, and in doing so, propelling the possibility of early disease detection and precision care for patients on Earth.

For astronauts on long space missions, dropping into a clinic upon the first signs of a medical condition is not an option. In light of this, the astronauts’ health needs to be vigilantly monitored before take-off. Using genomic analysis techniques, space health teams are able to predict the risk of a particular disease developing in an individual and customize a preventative intervention plan accordingly. 

Dr. Sobel uses a variety of genomics, proteomics and metabolomics tools which allow her team to simulate disease progression based on a person’s genetic profile. Our genetic code holds a wealth of information: the number and combinations of genes speak to the chances of developing certain diseases, as well as the potential for experiencing side effects to drugs.

Here on earth, lessons learned from these innovations are already being translated to a better standard of care for many common illnesses. For instance, glaucoma is a leading cause of blindness in people over 60, caused by abnormally high pressure in the eyeball. Now, an increased understanding of the genetics of glaucoma progression, using the same techniques used to study astronauts, can empower clinicians and patients with more predictive power to halt disease progression earlier.

The next frontier for personalized medicine could mean that, like astronauts headed for galaxy explorations, we no longer have to wait for symptoms to develop before receiving clinical care.

Source: Mobi Health News

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 18, 2019
Health & Medicine
SEP 18, 2019
Honey As An Antibacterial Against Methicillin-Resistant Staphylococcus Aureus
Honey has been used for its medicinal properties for thousands of years to treat wound infections, gastrointestinal...
NOV 05, 2019
Clinical & Molecular DX
NOV 05, 2019
Meningitis and Encephalitis: Testing & Diagnosis Strategies for Effective Treatment
Meningitis is an inflammation of the membranes surrounding the brain (meninges) and spinal cord. Encephalitis, on the ot...
DEC 04, 2019
Clinical & Molecular DX
DEC 04, 2019
Genetic platform takes the guesswork out of catching infections
A physician is faced with 3 patients: an elderly person with a chronic cough, a child being wheeled out of surgery and a young mother with a high fever. Ho
JAN 14, 2020
Clinical & Molecular DX
JAN 14, 2020
Can I eat this donut? A quick test for celiac disease.
Genetic testing revealed that our ancestors have been eating wheat, rye, spelt and barley for over 8,000 years. Today, gluten, a protein found within these
FEB 10, 2020
Microbiology
FEB 10, 2020
As Ebola Outbreak Continues, Researchers Create Faster Genetic Test
Since 2013, around 30,000 people have been infected during several outbreaks of Ebola in eight different countries.
MAR 05, 2020
Drug Discovery & Development
MAR 05, 2020
Human Stem Cells Cure Type 1 Diabetes in Mice
In the US alone, around 187,000 children and adolescents have Type 1 diabetes, alongside 1.4 million people aged 20 and over. Managing their condition with
Loading Comments...